Comments: TN SB2091 | 2015-2016 | 109th General Assembly
Bill Title: As introduced, prohibits an insurance policy that provides benefits for anti-cancer medications that are injected or intravenously administered by a healthcare provider and anti-cancer medications that are patient administered from requiring a higher copayment, deductible, or coinsurance amount. - Amends TCA Title 56, Chapter 7, Part 23.
Spectrum: Partisan Bill (Republican 8-0)
Status: (Failed) 2016-03-01 - Failed in Senate Commerce & Labor Committee [SB2091 Detail]
Text: Latest bill text (Draft #2) [PDF]
Spectrum: Partisan Bill (Republican 8-0)
Status: (Failed) 2016-03-01 - Failed in Senate Commerce & Labor Committee [SB2091 Detail]
Text: Latest bill text (Draft #2) [PDF]
PolitiCorps Conversations
Start PolitiCorps DebateTitle | PolitiCorps | Access | Comments | Views | Last Post |
---|---|---|---|---|---|
There are no visible public or private PolitiCorps discussions concerning the 2015 Tennessee SB2091 at this time. |